AlphAIalphai — Financial news for AI agents
BenzingaJUN 93 min read$OGI

Are Tobacco Companies Ready To Invest In Cannabis? - Organigram Global (NASDAQ:OGI)

Large global tobacco companies have made small investments in the cannabis space. Industry experts break down what could be next and why investments have been conservative to date. Get access to the leaderboards pointing to tomorrow's biggest stock movers.

Original reporting
Benzinga · Chris Katje
Published Jun 9, 2025, 4:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2025, 5:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Are Tobacco Companies Ready To Invest In Cannabis? - Organigram Global (NASDAQ:OGI) — source image
Source · www.benzinga.com
Decision brief

The 30-second read

$OGINeutralLow
01

Why it matters

The article highlights potential industry shifts but emphasizes that significant investment activity remains limited, leading to a neutral short-term market impact.

02

Market read

Moderate relevance for investors interested in cannabis and tobacco sectors; primarily long-term implications.

03

What to watch

Regulatory hurdles and market saturation could impede growth, which are not fully addressed in the article.

Timing: Long-term

Background

Tobacco companies have historically been conservative investors in cannabis, focusing on strategic positioning rather than aggressive expansion.

Company-level read

Ticker impact

$OGINeutralMedium confidence
Context

High relevance due to direct involvement in cannabis investments and industry sentiment.

Expected impact

Minimal immediate price movement; potential for gradual appreciation over 6-12 months if investments increase.

Evidence & confidence

Limited current investment activity and neutral market sentiment suggest modest near-term impact, but industry growth potential supports a positive outlook.

Market effects

Sector

Potential growth in the cannabis sector driven by tobacco industry investments.

Regional

Primarily North America, with possible expansion to other regions as investments grow.

Global

Moderate, depending on international regulatory developments.

Counterpoint

What could challenge this read

The cautious approach of tobacco companies may indicate limited growth prospects in cannabis, suggesting that current valuations could be overstated.

Key entities

  • Company
    Organigram Global

    A Canadian cannabis producer listed on NASDAQ.

  • Source
    Benzinga

    Financial news outlet providing industry insights.

Read at source← All news

Related articles

JUN 1
$OGIMedAI 9/10

Organigram Global Inc (OGI) Raises 2026 Guidance on Sanity Acquisition

Organigram Global Inc (NASDAQ:OGI) reported March-quarter results on May 12. Net revenue fell 9% YoY to $59.8M and adjusted EBITDA was $0.9M versus $4.9M a year earlier, citing weakness in vapes, pre-roll production issues, and slower industry growth. The company raised 2026 revenue guidance to $350M from $300M, expecting Sanity Group (acquired end of March) to add about €25M quarterly revenue.

finance.yahoo.com5 min
AUG 9
$BAMed

Pentagon seeks weapons production boost

Pentagon deputy secretary Steve Feinberg asked major U.S. defense firms to accelerate production and deliveries of weapons and sensors, citing concerns about shortages and gaps tied to the Iran conflict. In an Aug. 5 letter seen by Bloomberg, he targeted programs including wide-area surveillance, air-defense sensors and interceptors, and missile-tracking systems, asking for plans by late August.

bostonherald.com6 min
AUG 9
$BTDRMedAI 8/10

How Investors Are Reacting To Bitdeer Technologies Group (BTDR) Securing A 16-Year AI Data Center Deal

Bitdeer Technologies Group (BTDR) said its Tydal Data Center subsidiary in Norway signed a 16-year colocation lease and services deal with Volta Tydal AS for 121 MW and about $4.70 billion in contracted revenue, with an 8-year renewal option that could raise total value to about $8.0 billion. The campus is renewable-powered, set for NVIDIA GPU clusters, and includes $1.30 billion in credit support.

simplywall.st6 min
AUG 9
$CORZMed

Core Scientific (CORZ) Shareholders Rejected a $9B Sale. Does the AMD Deal Vindicate Them?

Core Scientific (CORZ) said it signed a 15-year infrastructure partnership with AMD (AMD) for data-center power starting in 2027. The deal covers about 530 MW across five sites, with AMD leasing 377 MW and a neocloud leasing 152 MW. Core Scientific said it has $14B+ potential base contracted revenue. The news follows shareholders rejecting a CoreWeave all-stock deal valued around $9B.

yahoo.com6 min
AUG 9
$LMTMed

What is the Patriot missile system and why are supplies depleted worldwide?

Reuters explains the U.S. Patriot mobile air defense system, built by Raytheon Technologies, and its PAC-2 and PAC-3 interceptor variants. Demand has risen as Russia’s strikes in Ukraine and the Middle East conflict have depleted interceptor stocks. CSIS estimates about 65% of U.S. interceptors were used Feb-July, leaving under 850. Lockheed received a contract up to $58.6B.

internazionale.it6 min